LG Chem is set to establish a $3 billion battery cathode factory for electric vehicles (EVs) in Tennessee. Additionally, it has inked a long-term cathode material supply contract with General Motors (GM) worth a staggering $19 billion.

LG Chem is set to establish a $3 billion battery cathode factory for electric vehicles (EVs) in Tennessee. Additionally, it has inked a long-term cathode material supply contract with General Motors (GM) worth a staggering $19 billion.
Toyota Advances its Commitment to vehicle electrification, Toyota will assemble three-row, battery electric SUV at Toyota Kentucky starting in 2025
ImmPACT Bio Announces California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases
Pharmaceutical Engineering® magazine is proud to announce the 2021 Roger F. Sherwood Article of the Year is “Medical Device UDI Components Management in the European Union”
Millstone Medical Outsourcing announces the groundbreaking for a third cleanroom facility expansion at its Fall River, MA headquarters.
The Pennsylvania Biotechnology Center partnership offers biotech residents flexible, plug & play lab and research...
Joint marketing and technology collaboration will leverage strengths of two market leaders to provide nanoimprint lithography development kits and foster industrial-scale implementation
ILC Doveror specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market.
SteriPack Group, a leading global contract manufacturer, today announced it has expanded its high-quality sample collection line with two new swab products.
Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide
SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.